Institutionelt og fondsejerskab - Købere
Større indehavere, der har åbnet nye stillinger i Moleculin Biotech, Inc., omfatter Sabby Management, Llc, Vanguard Group Inc, Vanguard Capital Management Llc, Hrt Financial Lp, Vanguard Fiduciary Trust Co, Vanguard Global Advisers, LLC, Fmr Llc, og Caitong International Asset Management Co., Ltd .
Denne side viser ændringer i ejerskabsstrukturen ved at notere institutioner, fonde og større aktionærer, der har øget deres beholdning eller åbnet nye positioner i den seneste rapporteringsperiode. Grønne rækker angiver nye positioner. Klik på linket ikon for at se den fulde transaktionshistorik.
Opgrader for at låse op for premium-data.
| Fil dato | Kilde | Investor | Type | Gennemsnitlig pris (Øst) |
Aktier | Δ Aktier (%) |
Rapporteret Værdi ($1000) |
Δ Værdi (%) |
Port Alloc (%) |
|
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | 13F | Fmr Llc | 3 | 0 | ||||||
| 2026-05-15 | 13F | Geode Capital Management, Llc | 32.329 | 113,56 | 74 | 48,00 | ||||
| 2026-05-15 | 13F/A | Vanguard Capital Management Llc | 13.869 | 32 | ||||||
| 2026-01-29 | 13F | Vanguard Group Inc | 15.544 | 51 | ||||||
| 2026-05-14 | 13F | Hrt Financial Lp | 13.739 | 0 | ||||||
| 2026-05-15 | 13F | Sabby Management, Llc | 75.021 | 172 | ||||||
| 2026-04-28 | 13F | SBI Securities Co., Ltd. | 43 | 0 | ||||||
| 2026-05-14 | 13F | Rockefeller Capital Management L.P. | 4.421 | 1.927,98 | 10 | |||||
| 2026-05-08 | 13F | Vanguard Global Advisers, LLC | 24 | 0 | ||||||
| 2026-05-11 | 13F | Caitong International Asset Management Co., Ltd | 2 | 0 | ||||||
| 2026-05-08 | 13F | Vanguard Fiduciary Trust Co This fund is a listed as child fund of Vanguard Group Inc and if that institution has disclosed ownership in this security, then these positions will not be double counted when calculating total shares and total value | 6.072 | 14 | ||||||
| 2026-05-15 | 13F | Tower Research Capital LLC (TRC) | 1.835 | 31,73 | 4 | 0,00 |
